Leila Alland
Direttore/Membro del Consiglio presso ABEONA THERAPEUTICS INC.
Patrimonio netto: 446 468 $ in data 31/05/2024
Profilo
Leila Alland is currently an Independent Director at Abeona Therapeutics, Inc., a Director at Jubilant Therapeutics, Inc., and a Non-Executive Director at Radiopharm Theranostics Ltd.
She previously worked as a Director at Cytovia Therapeutics, Inc. from 2020 to 2022, Chief Medical Officer at Affimed NV from 2018 to 2019, Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. from 1994 to 2000, Vice President & Head-Oncology at AstraZeneca LP from 2013 to 2015, and Chief Medical Officer at Tarveda Therapeutics, Inc. from 2016 to 2018.
Dr. Alland is also currently serving as the Chief Medical Officer at PMV Pharmaceuticals, Inc. since 2019.
She completed her undergraduate degree at the University of Pennsylvania and holds a doctorate from New York University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 16/05/2024 | 82 857 ( 0.20% ) | 362 914 $ | 31/05/2024 | |
| 15/09/2023 | 45 909 ( 0.09% ) | 83 554 $ | 31/05/2024 |
Posizioni attive di Leila Alland
| Società | Posizione | Inizio |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 19/04/2021 |
| RADIOPHARM THERANOSTICS LIMITED | Direttore/Membro del Consiglio | 06/06/2022 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Direttore/Membro del Consiglio | 16/08/2021 |
Precedenti posizioni note di Leila Alland
| Società | Posizione | Fine |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2023 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 01/02/2022 |
| AFFIMED N.V. | Direttore Tecnico/Scientifico/R&S | 30/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Direttore Tecnico/Scientifico/R&S | 01/03/2018 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01/12/2015 |
Formazione di Leila Alland
| New York University School of Medicine | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| AFFIMED N.V. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| ABEONA THERAPEUTICS INC. | Health Technology |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Aziende private | 4 |
|---|---|
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Health Technology |
- Borsa valori
- Insiders
- Leila Alland
